Boehringer Ingelheim Renews Global SRS License
Complete the form below to unlock access to ALL audio articles.
BioWisdom SRS has announced that Boehringer Ingelheim has extended its SRS and SRS Prisma licenses as well as its Support and Maintenance agreements for another year.
SRS has been in use at Boehringer Ingelheim for the past 5 years and is an integral part of its Bioinformatics platform.
As part of the renewal agreement BioWisdom SRS will be responsible for upgrading the Biberach (Germany) and Ridgefield (USA) sites to new versions of the software.
"Renewing customers is the best endorsement for the SRS product," said Gordon Smith Baxter, CEO of BioWisdom.
"Feedback from long term customers, such as Boehringer Ingelheim, is essential for the SRS team to continue to provide software with a strong value proposition and we are pleased to be working with them for another year."
